Deciphering immune microenvironment and cell evasion mechanisms in human gliomas

• Published in: Frontiers in oncology Vol. 13; p. 1135430
• Main Authors: Rafii, Soumaya, Kandoussi, Sarah, Ghouzlani, Amina, Naji, Oumayma, Reddy, Konala Priyanka, Ullah Sadiqi, Rizwan, Badou, Abdallah
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 19.05.2023
• Subjects: glioma; glioma cell evasion; immune checkpoints; immune microenvironment; immunotherapy; Oncology; therapy resistance; glioma; immune microenvironment; glioma cell evasion; immunotherapy; immune checkpoints; therapy resistance
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2023.1135430

Gliomas are considered one of the most malignant cancers in the body. Despite current therapies, including surgery, chemotherapy, and radiotherapy, these tumors usually recur with more aggressive and resistant phenotypes. Indeed, the survival following these conventional therapies is very poor, which makes immunotherapy the subject of active research at present. The anti-tumor immune response could also be considered a prognostic factor since each stage of cancer development is regulated by immune cells. However, glioma microenvironment contains malignant cells that secrete numerous chemokines, cytokines and growth factors, promoting the infiltration of immunosuppressive cells into the tumor, which limit the functioning of the immune system against glioma cells. Recently, researchers have been able to reverse the immune resistance of cancer cells and thus activate the anti-tumor immune response through different immunotherapy strategies. Here, we review the general concept of glioma’s immune microenvironment and report the impact of its distinct components on the anti-tumor immune response. We also discuss the mechanisms of glioma cell evasion from the immune response and pinpoint some potential therapeutic pathways, which could alleviate such resistance.